Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical College of Wisconsin
Janssen Research & Development, LLC
City of Hope Medical Center
City of Hope Medical Center
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Illinois at Chicago
National Heart, Lung, and Blood Institute (NHLBI)
University of Nebraska
Washington University School of Medicine
Duke University
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northside Hospital, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Ludwig Institute for Cancer Research
Hackensack Meridian Health
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
University of Iowa
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
University of Arkansas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Mayo Clinic
Albert Einstein College of Medicine
University of California, San Francisco
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Acrotech Biopharma Inc.
Washington University School of Medicine
Celgene
Roswell Park Cancer Institute
University of Illinois at Chicago
Mayo Clinic
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Arizona
Amgen
M.D. Anderson Cancer Center
City of Hope Medical Center